Skip to main content
Caplight Logo









Paulex Bio Inc.

Paulex Bio Inc.

Private
La Jolla, CaliforniaHealthcare & Life Scienceshttps://paulexbio.com/

Last Round

Seed

Dec 18, 2025

Total Funding Raised

$18.52M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Paulex Bio Inc. is a biotechnology company that develops regeneration therapies for the treatment and prevention of Type-1 and Type-2 Diabetes.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

beta cell regenerationDYRK1A inhibitordiabetes treatmentoral diabetes drugsmall molecule drugregenerative medicinediabetes cureType 1 diabetesType 2 diabetesdisease-modifying therapypreclinical biotechbiopharmaceuticaldrug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Paulex Bio Inc. Comparables

Compare Paulex Bio Inc. with similar companies based on industry and business-model similarity.

Paulex Bio Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Betavive Ltd.
81%
DiogenX
81%
Biomea Fusion
80%

Paulex Bio Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 18, 2025

Key People

Founding team and executive leadership

Miguel Sanjuan

CEO & Founder

Founding Team

Paulex Bio Inc. Investors

Notable investors and investment history

Paulex Bio Inc. investors
InvestorRounds
LifeSpan Vision VenturesSeed
TCA Venture GroupSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 18, 2025

    $19M round led by LifeSpan Vision Ventures and MDB Capital Holdings.

Paulex Bio Inc. Filings

Explore SEC and related filing metadata, where available.

Paulex Bio Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Paulex Bio Inc.'s valuation, stock price, and market status.

Is Paulex Bio Inc. a public or private company?

Paulex Bio Inc. is a private company.

What is the current stock price of Paulex Bio Inc.?

Paulex Bio Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Paulex Bio Inc. worth (valuation)?

Valuation information for Paulex Bio Inc. is not publicly available.

Can I buy Paulex Bio Inc. stock?

Paulex Bio Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Paulex Bio Inc.'s last funding round?

Funding round information for Paulex Bio Inc. is not publicly available.

Who are the main investors in Paulex Bio Inc.?

Investor information for Paulex Bio Inc. is not publicly disclosed.

Will Paulex Bio Inc. IPO soon?

No public IPO plans have been announced for Paulex Bio Inc..

How can I track Paulex Bio Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Paulex Bio Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLa Jolla, California
Employee Range4
Year Founded2023
Last FundingDec 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?